Labcorp will begin offering a new blood-based biomarker test for Alzheimer’s disease, developed by Roche and Eli Lilly, starting in early 2026. This test, known as...
South Korea’s Celltrion has finalized the acquisition of Eli Lilly‘s production facility located in Branchburg, New Jersey, for $330 million. This transaction, confirmed through a regulatory...
